- No, GRAS Isn’t Just About Vinegar March 20, 2026
- WEBINAR: Navigating Orphan Medicines Regulation: Strategic Insights from the US and Europe – April 14th, 10:00 to 11:00 ET March 19, 2026
- Job Opportunity: HPM Seeks Junior to Mid-Level Attorney with Healthcare Law Experience March 17, 2026
- PK Studies in the Crosshairs: FDA Revises Biosimilar Development Guidance March 16, 2026
- Don’t Just Say “We’ll Fix It”: FDA Wants Real Investigations in Your 483 Response March 13, 2026
- Big Molecule Watch Blog
- Bloomberg BNA Health Care Blog
- Drug and Device Law Blog
- Eye on FDA
- FDA Matters
- Harvard Law Bill of Health
- IN VIVO Blog
- Internet Drug News.com
- Lachman Consultants Blog
- Medical Devices Today
- Orange Book Blog
- The Orange Book Insights Blog
- Pharma IQ
- Pharmalot
- SCOTUS Blog
- The Volokh Conspiracy
- WLF Legal Pulse
- Advertising and Promotion (Federal Trade Commission)
- Advertising and Promotion (OPDP)
- Animal Drugs and Feeds
- Biosimilars
- Cannabis
- cGMP Compliance
- Consumer Product Safety Commission
- Controlled Substances
- Cosmetics
- COVID19
- Current Affairs
- Dietary Supplements
- Drug Development
- Drug Enforcement Administration
- Enforcement
- FDA News
- Foods
- Foods and Dietary Supplements
- Fraud and Abuse
- Government Pricing
- Hatch-Waxman
- Health Care
- Health Privacy
- Import/Export
- In Vitro Diagnostic Devices
- Jobs
- Medical Devices
- Miscellaneous
- Orphan Drugs
- OTC Drugs and Cosmetics
- Prescription Drugs and Biologics
- Product Jurisdiction and Combination Products
- Reimbursement
- Tissue Products
- Tobacco
- Uncategorized
FDA Law Blog Welcomes Scott Hensley Back to the Blogosphere
August 10, 2009FDA Law Blog welcomes back to the blogosphere our friend Scott Hensley, formerly of the Wall Street Journal (where he was the founding editor and a regular contributor to the paper’s Health Blog). Scott will be blogging at the National Public Radio Health Blog and appearing on NPR as well. The NPR Health Blog covers news about health and medicine, including FDA-related issues, and is written and reported by NPR’s Science Desk.
Categories: Miscellaneous
Search FDA Law Blog
Subscribe
Latest Tweets
Tweets by @fdalawblogAwards & Honors
- Best Lawyers in America® – 2025
- Ranked in Chambers USA – 2024
- No, GRAS Isn’t Just About Vinegar March 20, 2026
- WEBINAR: Navigating Orphan Medicines Regulation: Strategic Insights from the US and Europe – April 14th, 10:00 to 11:00 ET March 19, 2026
- Job Opportunity: HPM Seeks Junior to Mid-Level Attorney with Healthcare Law Experience March 17, 2026
- PK Studies in the Crosshairs: FDA Revises Biosimilar Development Guidance March 16, 2026
- Don’t Just Say “We’ll Fix It”: FDA Wants Real Investigations in Your 483 Response March 13, 2026
- Big Molecule Watch Blog
- Bloomberg BNA Health Care Blog
- Drug and Device Law Blog
- Eye on FDA
- FDA Matters
- Harvard Law Bill of Health
- IN VIVO Blog
- Internet Drug News.com
- Lachman Consultants Blog
- Medical Devices Today
- Orange Book Blog
- The Orange Book Insights Blog
- Pharma IQ
- Pharmalot
- SCOTUS Blog
- The Volokh Conspiracy
- WLF Legal Pulse
- Advertising and Promotion (Federal Trade Commission)
- Advertising and Promotion (OPDP)
- Animal Drugs and Feeds
- Biosimilars
- Cannabis
- cGMP Compliance
- Consumer Product Safety Commission
- Controlled Substances
- Cosmetics
- COVID19
- Current Affairs
- Dietary Supplements
- Drug Development
- Drug Enforcement Administration
- Enforcement
- FDA News
- Foods
- Foods and Dietary Supplements
- Fraud and Abuse
- Government Pricing
- Hatch-Waxman
- Health Care
- Health Privacy
- Import/Export
- In Vitro Diagnostic Devices
- Jobs
- Medical Devices
- Miscellaneous
- Orphan Drugs
- OTC Drugs and Cosmetics
- Prescription Drugs and Biologics
- Product Jurisdiction and Combination Products
- Reimbursement
- Tissue Products
- Tobacco
- Uncategorized